CliffBio
small molecule

ULTRAVIST 150

IOPROMIDE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameULTRAVIST 150
Active ingredientIOPROMIDE
Strength31.2%
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalMay 1995
Marketing statusDISCN

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.